Shame the EU banned selling them in shell because they thought the shells caused cancer

Yes it certainty could, but unfortunately, NICE has passed it for use in every other cancer apart from prostate cancer

Hi Colin, you are quite right, yes of course bone health should be monitored, but the fact remains that hormone treatment causes osteoporosis and this could be avoided. After 5 years on hormone therapy, a man could lose considerably more bone density than 2%. This becomes much more of a problem with...

Every other cancer has a NICE treatment pathway for bone health when it has metastasised. Not so with prostate cancer! The only treatment for advanced prostate cancer is hormone treatment, which causes osteoporosis and eventually skeletal related events (SRE's). This means bone fractures and the pos...

The new advance prostate cancer drug Enzalutamide is now available under the CDF, but NOT if you have been given Abiraterone first. This ruling precludes the very men who need it and is grossly unfair. As a matter of urgency, please write to your MP to register your disapproval of this. Lives depend...